Trials / Completed
CompletedNCT00333372
To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia
To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia, Focusing on the Assessment of Subjective Symptoms
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 440 (planned)
- Sponsor
- Zeria Pharmaceutical · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
To Evaluate the efficacy of Z-338 in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms in order to further determine the optimal dosage and efficacy parameters for PhaseIII clinical trials.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Z-338 |
Timeline
- Start date
- 2006-04-01
- First posted
- 2006-06-05
- Last updated
- 2009-01-14
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00333372. Inclusion in this directory is not an endorsement.